CORT - Corcept Therapeutics Incorporated (CORT) Q1 2024 Earnings Call Transcript
2024-05-01 23:42:02 ET
Corcept Therapeutics Incorporated (CORT)
Q1 2024 Earnings Conference Call
May 1, 2024 17:00 ET
Company Participants
Atabak Mokari - Chief Financial Officer
Charlie Robb - Chief Business Officer
Joe Belanoff - Chief Executive Officer
William Guyer - Chief Development Officer
Sean Maduck - President, Corcept Endocrinology
Conference Call Participants
Matt Kaplan - Ladenburg
David Amsellem - Piper Sandler
Swayampakula Ramakanth - H.C. Wainwright
Presentation
Operator
Good day and thank you for standing by. Welcome to the Corcept Therapeutics Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to turn the conference over to your speaker for today, CFO, Atabak Mokari. Please go ahead.
Atabak Mokari
Hello, everyone and thank you for joining us. Today, we issued a press release announcing our financial results for the first quarter and providing a corporate update. A copy is available at corcept.com. Our complete financial results will be available when we file our Form 10-Q with the SEC. Today’s call is being recorded. A replay will be available at the Investors Past Events tab of our website.
Statements during this call, other than statements of historical fact are forward-looking statements based on our plans and expectations that are subject to risks and uncertainties which may cause actual results to be materially different from those such statements expressed or implied. These forward-looking statements are described in today’s press release and the risks and uncertainties that may affect them are described in the press release and in our annual report on Form 10-K and our quarterly reports on Form 10-Q. Please refer to those documents for additional information. We disclaim any intention or duty to update forward-looking statements....
Corcept Therapeutics Incorporated (CORT) Q1 2024 Earnings Call Transcript